337 related articles for article (PubMed ID: 11536039)
1. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
2. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
Allay E; Reese JS; McGuire EA; KoƧ ON; Sedransk N; Gerson SL
Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
[TBL] [Abstract][Full Text] [Related]
4. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
Liu L; Allay E; Dumenco LL; Gerson SL
Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
Qin X; Zhou H; Liu L; Gerson SL
Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
[TBL] [Abstract][Full Text] [Related]
6. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
Qin X; Liu L; Gerson SL
Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
[TBL] [Abstract][Full Text] [Related]
7. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.
Boley SE; McManus TP; Maher VM; McCormick JJ
Cancer Res; 2000 Aug; 60(15):4105-11. PubMed ID: 10945617
[TBL] [Abstract][Full Text] [Related]
9. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea.
Brathwaite O; Bayona W; Newcomb EW
Cancer Res; 1992 Jul; 52(13):3791-5. PubMed ID: 1617648
[TBL] [Abstract][Full Text] [Related]
11. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.
Zaidi NH; Allay E; Ayi TC; Li BF; Dumenco LL; Sy MS; Gerson SL
Carcinogenesis; 1995 May; 16(5):1047-53. PubMed ID: 7767963
[TBL] [Abstract][Full Text] [Related]
12. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.
Sakumi K; Shiraishi A; Shimizu S; Tsuzuki T; Ishikawa T; Sekiguchi M
Cancer Res; 1997 Jun; 57(12):2415-8. PubMed ID: 9192819
[TBL] [Abstract][Full Text] [Related]
13. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
[TBL] [Abstract][Full Text] [Related]
14. Alkyltransferase transgenic mice: probes of chemical carcinogenesis.
Gerson SL; Zaidi NH; Dumenco LL; Allay E; Fan CY; Liu L; O'Connor PJ
Mutat Res; 1994 Jun; 307(2):541-55. PubMed ID: 7514728
[TBL] [Abstract][Full Text] [Related]
15. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
16. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
Gerson SL; Trey JE; Miller K; Benjamin E
Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
[TBL] [Abstract][Full Text] [Related]
17. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice.
Benavides F; Gomez G; Venables-Griffith A; Lambertz I; Flores M; Angel JM; Fuchs-Young R; Richie ER; Conti CJ
Mol Carcinog; 2006 Jul; 45(7):543-8. PubMed ID: 16479612
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
[TBL] [Abstract][Full Text] [Related]
20. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]